Industry Support Key To US FDA’s Prospects Under Trump – Califf

The FDA's current leader, whose term will end with Donald Trump’s second inauguration, also described three qualities the agency’s next commissioner will need to succeed, including "believing that there is such a thing as expertise."

FDA Commissioner Robert Califf spoke at the Friends of Cancer Research Annual Meeting on 12 November. (Screenshot of Internet Broadcast)

How the US Food and Drug Administration fares during President-elect Donald Trump’s second term will depend, in part, on industry’s support for the agency and its staff, says Commissioner Robert Califf.

More from Legislation

More from Wellness